8-K: Beneficient Closes $233,333 GP Primary Capital Transaction with Cork & Vines Fund I, LP
Current Report (Form 8-K)
Beneficient has closed a primary capital transaction, providing $233,333 to Cork & Vines Fund I, LP in exchange for shares of the company's Resettable Convertible Preferred Stock.
Summary
- Beneficient closed a primary capital transaction on April 21, 2025, through a subsidiary.
- The transaction involved a limited partner interest in an investment fund with a net asset value of $233,333.
- In exchange, the customer received 23,333 shares of Series B-7 Resettable Convertible Preferred Stock.
- The Series B-7 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.2979 per share, subject to a floor of $0.2234 per share.
- A maximum of 1,044,450 shares of Class A Common Stock may be issued upon conversion.
- The company filed a certificate of designation for the Series B-7 Preferred Stock with the Secretary of State of Nevada.
- The company also entered into a Preferred Liquidity Provider Program Agreement with the Fund to facilitate ongoing liquidity solutions.
- The company believes this transaction will result in the addition of approximately $77,777 (and an aggregate of approximately $10.54 million) of tangible book value attributable to the company's stockholders upon closing of the previously announced Public Stockholder Enhancement Transactions.
Sentiment
Score: 7
Explanation: The document presents a positive outlook with the closing of a new transaction and expected benefits to the company's balance sheet. However, it also includes forward-looking statements and risks, which temper the overall sentiment.
Positives
- The transaction provides primary capital to Cork & Vines Fund I, LP.
- Beneficient expects an increase in the collateral for its ExAlt loan portfolio by approximately $233,333.
- The company anticipates an increase in tangible book value attributable to stockholders by approximately $77,777 (and an aggregate of approximately $10.54 million) upon closing of the previously announced Public Stockholder Enhancement Transactions.
- The Preferred Liquidity Provider Program Agreement may provide ongoing liquidity solutions for the Fund and its limited partners.
Risks
- The conversion of Series B-7 Preferred Stock is subject to beneficial ownership limitations and exchange caps.
- The ultimate outcome of the Public Stockholder Enhancement Transactions is uncertain, which could impact the expected increase in tangible book value.
- The company's ability to meet expectations regarding the timing and completion of the Transactions is not guaranteed.
Future Outlook
Beneficient intends to continue pursuing additional opportunities that align with its strategic vision and growth objectives, focusing on primary capital solutions and financing anchor commitments to general partners.
Management Comments
- We are excited to continue the momentum at the outset of this fiscal year by completing another GP primary capital transaction as we work to execute on our core liquidity and primary capital strategy, said Beneficient management.
- We believe this financing reflects our ability to close transactions that drive shareholder value and enhance the value of the collateral backing our ExAlt loan portfolio.
Industry Context
This transaction reflects a continued interest in providing liquidity and capital solutions within the alternative asset market, particularly for general partners seeking primary capital commitments.
Comparison to Industry Standards
- It is difficult to compare this specific transaction to industry standards without knowing the specific terms of the limited partner interest acquired and the typical returns expected from funds like Cork & Vines Fund I, LP.
- However, the company's focus on providing liquidity solutions for alternative assets aligns with a growing trend in the financial industry, as more investors seek access to these traditionally illiquid assets.
- Companies like Apollo Global Management and Blackstone also have significant alternative asset management businesses, but their scale and focus differ from Beneficient's niche in providing liquidity and primary capital solutions to underserved investors.
Stakeholder Impact
- Shareholders may benefit from the expected increase in tangible book value.
- The transaction provides capital to Cork & Vines Fund I, LP, potentially benefiting its investors.
- The ExAlt loan portfolio is expected to increase in value, potentially benefiting Beneficient's creditors.
Next Steps
- The company will continue to pursue additional opportunities that align with its strategic vision and growth objectives.
- The company awaits the closing of the previously announced Public Stockholder Enhancement Transactions.
Key Dates
| Date | Description |
|---|---|
| March 31, 2024 | End of fiscal year for which Form 10-K was filed on July 9, 2024 |
| July 9, 2024 | Date of filing of Annual Report on Form 10-K for the fiscal year ended March 31, 2024 |
| December 22, 2024 | Date related to ExAlt Plan liquidity and primary capital transactions |
| April 21, 2025 | Date of primary capital transaction and filing of certificate of designation for Series B-7 Preferred Stock |
| April 24, 2025 | Date used for market capitalization calculation |
| April 25, 2025 | Date of press release and Form 8-K filing |
Keywords
primary capital, Beneficient, convertible preferred stock, alternative assets, liquidity, ExAlt loan portfolio, Cork & Vines Fund I, LP, tangible book value
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.